Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Shobha Upreti, Mukesh Samant
Pharmaceutical Research (2022) Vol. 39, Iss. 9, pp. 2119-2134
Open Access | Times Cited: 24

Showing 24 citing articles:

Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Deep, Unbiased, and Quantitative Mass Spectrometry-Based Plasma Proteome Analysis of Individual Responses to mRNA COVID-19 Vaccine
Ting Huang, Alex Campos, Jian Wang, et al.
Journal of Proteome Research (2025)
Closed Access
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
Alexandra Rak, Svetlana Donina, Yana Zabrodskaya, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2041-2041
Open Access | Times Cited: 25
The humoral and cellular response to mRNA SARS‐CoV ‐2 vaccine is influenced by HLA polymorphisms
Francesca Bertinetto, Paola Magistroni, G. Mazzola, et al.
HLA (2023) Vol. 102, Iss. 3, pp. 301-315
Open Access | Times Cited: 13
The COVID-19 inflammation and high mortality mechanism trigger
Samuel Stróż, Piotr Kosiorek, Anna Stasiak‐Barmuta
Immunogenetics (2023) Vol. 76, Iss. 1, pp. 15-25
Closed Access | Times Cited: 11
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine
Leah J. McGrath, Deepa Malhotra, Amanda C. Miles, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2342151-e2342151
Open Access | Times Cited: 9
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Profiling of Early Immune Responses to Vaccination Using THP-1-Derived Dendritic Cells
Lei Ye, Li Ping, Mingzhe Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5509-5509
Open Access | Times Cited: 2
The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study
Yuxiao Wang, Ying Qiao, Yuqi Huo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Spotlight on contributory role of host immunogenetic profiling in SARS-CoV-2 infection: Susceptibility, severity, mortality, and vaccine effectiveness
Somayeh Yazdanparast, Mehdi Bakhtiyaridovvombaygi, Fatemeh Mikanik, et al.
Life Sciences (2023) Vol. 328, pp. 121907-121907
Open Access | Times Cited: 7
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, et al.
Human Antibodies (2024) Vol. 32, Iss. 3, pp. 85-106
Closed Access | Times Cited: 1
Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineages
Yanhua Li, Shijie Qin, Lei Dong, et al.
EBioMedicine (2024) Vol. 110, pp. 105428-105428
Closed Access | Times Cited: 1
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individuals
Roberto Lozano‐Rodríguez, José Avendaño‐Ortiz, Verónica Terrón, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
STRATEGIES FOR VACCINE DEVELOPMENT OF COVID-19 IN THE WORLD
Mirkhamidova Sevara Mirmakhmudovna, Abrarul Haq, Ilyasova Munisa Mirvaliyevna, et al.
International Journal of Medical Sciences And Clinical Research (2023) Vol. 03, Iss. 03, pp. 5-19
Open Access | Times Cited: 2
Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake
Michael L. Mallory, Jennifer E. Munt, Tara M. Narowski, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Deep, unbiased and quantitative mass spectrometry-based plasma proteome analysis of individual responses to mRNA COVID-19 vaccine
Ting Huang, Alex Campos, Jian Wang, et al.
(2024)
Closed Access
Clinic viral diagnostics, viral vaccines, and advanced immunology
Shobha Upreti, Mukesh Samant
Elsevier eBooks (2024), pp. 99-111
Closed Access
Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Research Square (Research Square) (2024)
Open Access
Efecto de la exposición previa a COVID-19, ocurrencia de brotes y tipo de vacuna en la respuesta inmune humoral de adultos mayores institucionalizados
María Fernanda Aguirre, María Jimena Marro, Pamela Elizabeth Rodríguez, et al.
Cadernos de Saúde Pública (2024) Vol. 40, Iss. 9
Open Access
Impact of Sex, Age and Body Habitus on RBD-specific Antibody Response After Two Doses of Sinopharm BBIBP-CorV Vaccine
Tsogtsaikhan Sandag
(2024), pp. 1-7
Closed Access
Assessment of COVID‑19 vaccines in building immunity response through the measurement of anti‑spike protein antibodies
Mouad Najih, Rihabe Boussettine, Mohamed El Kehel, et al.
World Academy of Sciences Journal (2024) Vol. 7, Iss. 1
Open Access
Essential oil constituents of regional ethnomedicinal plants as potential inhibitors of SARS-CoV-2 M pro : an integrated molecular docking, molecular dynamics and QM/MM study
Ambalika Phonglo, Dikshita Dowerah, Srutishree Sarma, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-23
Closed Access
RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia
Burenjargal Batmunkh, Otgonbayar Dashpagma, Shatar Shaarii, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295167-e0295167
Open Access | Times Cited: 1
Page 1

Scroll to top